Evidence map›Paper›PMID 41804483›Full record

ArticlePeerJ2026

Peishan Cong, Biao Wang, Huiyang Qi, Guiming Zhang, Zhongjun Wang

Abstract read
In one paragraph

Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Peishan Cong *Department of Clinical Laboratory, Affiliated Hospital of Qingdao University, Qingdao, Shangdong, China.
Biao Wang *Department of Clinical Laboratory, Peking University People's Hospital, Qingdao, China; Women and Children's Hospital, Qingdao University, Qingdao, China.
Huiyang QiDepartment of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Guiming ZhangDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Zhongjun WangDepartment of Clinical Laboratory, Affiliated Hospital of Qingdao University, Qingdao, Shangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Candidemia is a major global public health problem due to the high mortality rates and increasing antifungal resistance. This study investigated the epidemiology and risk factors of candidemia in eastern China over the past 10 years. Methods: A descriptive, cross-sectional study was conducted from January 2015 to December 2024 in the Affiliated Hospital of Qingdao University to investigate the possible routes and risk factors of candidemia. Antifungal susceptibility was determined using broth microdilution method. Results: The incidence of candidemia increased from 0.98% to 1.69% over the past 10 years. In total 276 candidemia cases, Conclusions: The incidence of candidemia has increased in recent years, with

Indexed as

Antifungal AgentsCandidaCandidemiaAdolescentAdultAgedChildChinaCross-Sectional StudiesDrug Resistance, FungalFemaleHumansIncidenceMaleMicrobial Sensitivity TestsMiddle AgedAntifungal AgentsAntifungal susceptibilityCandida speciesCandidemiaRisk factors

Identifiers

PMID41804483
PMCPMC12967414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.